Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Potential Therapeutic drug Targets for Hypertension Identified using Proteomics and Mendelian Randomization

Submitted by Frida Mäkelä on Tue, 01/28/2025 - 13:03
  • Read more about Potential Therapeutic drug Targets for Hypertension Identified using Proteomics and Mendelian Randomization

Clonal hematopoiesis of indeterminate potential and type 2 diabetes mellitus among patients with STEMI: from a prospective cohort study combing bidirectional Mendelian randomization

Submitted by Frida Mäkelä on Tue, 01/28/2025 - 11:47
  • Read more about Clonal hematopoiesis of indeterminate potential and type 2 diabetes mellitus among patients with STEMI: from a prospective cohort study combing bidirectional Mendelian randomization

Maternal Smoking Around Birth Is a Risk Factor for Gastrointestinal Diseases in Offspring: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Tue, 01/28/2025 - 11:11
  • Read more about Maternal Smoking Around Birth Is a Risk Factor for Gastrointestinal Diseases in Offspring: A Mendelian Randomization Study

A genome-wide association study identifies genetic variants associated with hip pain in the UK Biobank cohort (N = 221,127)

Submitted by Frida Mäkelä on Tue, 01/28/2025 - 11:03
  • Read more about A genome-wide association study identifies genetic variants associated with hip pain in the UK Biobank cohort (N = 221,127)

Roles of cerebrospinal fluid metabolites in mediating the relationship between cathepsins and narcolepsy type 1: A comprehensive Mendelian randomization analysis

Submitted by Frida Mäkelä on Tue, 01/28/2025 - 10:56
  • Read more about Roles of cerebrospinal fluid metabolites in mediating the relationship between cathepsins and narcolepsy type 1: A comprehensive Mendelian randomization analysis

Effects of saturated and monounsaturated fatty acids on cognitive impairment: evidence from Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/23/2025 - 16:30
  • Read more about Effects of saturated and monounsaturated fatty acids on cognitive impairment: evidence from Mendelian randomization study

A comprehensive genetic map of cytokine responses in Lyme borreliosis

Submitted by Frida Mäkelä on Thu, 01/23/2025 - 16:23
  • Read more about A comprehensive genetic map of cytokine responses in Lyme borreliosis

Identification of early coagulation changes associated with survival outcomes post severe burns from multiple perspectives

Submitted by Frida Mäkelä on Thu, 01/23/2025 - 16:11
  • Read more about Identification of early coagulation changes associated with survival outcomes post severe burns from multiple perspectives

Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

Submitted by Frida Mäkelä on Thu, 01/23/2025 - 16:07
  • Read more about Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization

Effect of serum metabolites on the risk of iridocyclitis: a bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/23/2025 - 15:20
  • Read more about Effect of serum metabolites on the risk of iridocyclitis: a bidirectional Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • Current page 178
  • Page 179
  • Page 180
  • Page 181
  • Page 182
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement